Non-specific Effect of Vaccines: Immediate Protection against Respiratory Syncytial Virus Infection by a Live Attenuated Influenza Vaccine

被引:48
|
作者
Lee, Young J. [1 ]
Lee, Jeong Y. [2 ]
Jang, Yo H. [1 ]
Seo, Sang-Uk [3 ]
Chang, Jun [2 ,4 ]
Seong, Baik L. [1 ,4 ]
机构
[1] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Seoul, South Korea
[2] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea
[3] Seoul Natl Univ, Wide River Inst Immunol, Dept Biomed Sci, Coll Med, Seoul, South Korea
[4] Yonsei Univ, Vaccine Translat Res Ctr, Seoul, South Korea
来源
关键词
non-specific effects; cold-adapted live attenuated influenza vaccine; RSV; innate immunity; cross-protection; toll-like receptor; PLASMACYTOID DENDRITIC CELLS; IMMUNE-RESPONSES; INNATE IMMUNITY; A-VIRUS; INTERFERON INDUCTION; DONOR STRAIN; STRANDED-RNA; MICE; IMMUNOPATHOLOGY; IMMUNOGENICITY;
D O I
10.3389/fmicb.2018.00083
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The non-specific effects (NSEs) of vaccines have been discussed for their potential long-term beneficial effects beyond direct protection against a specific pathogen. Cold-adapted, live attenuated influenza vaccine (CAIV) induces local innate immune responses that provide a broad range of antiviral immunity. Herein, we examined whether X-31ca, a donor virus for CAIVs, provides non-specific cross-protection against respiratory syncytial virus (RSV). The degree of RSV replication was significantly reduced when X-31ca was administered before RSV infection without any RSV-specific antibody responses. The vaccination induced an immediate release of cytokines and infiltration of leukocytes into the respiratory tract, moderating the immune perturbation caused by RSV infection. The potency of protection against RSV challenge was significantly reduced in TLR3(-/-)TLR7(-/-)mice, confirming that the TLR3/7 signaling pathways are necessary for the observed immediate and short-term protection. The results suggest that CAIVs provide short-term, non-specific protection against genetically unrelated respiratory pathogens. The additional benefits of CAIVs in mitigating acute respiratory infections for which vaccines are not yet available need to be assessed in future studies.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Protection against respiratory syncytial virus infection by DNA immunization
    Li, XM
    Sambhara, S
    Li, CX
    Ewasyshyn, M
    Parrington, M
    Caterini, J
    James, O
    Cates, G
    Du, RP
    Klein, M
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (04): : 681 - 688
  • [32] Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics
    Murphy, BR
    Collins, PL
    JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (01): : 21 - 27
  • [33] A codon-pair deoptimized live-attenuated vaccine against respiratory syncytial virus is immunogenic and efficacious in non-human primates
    Mueller, Steffen
    Stauft, Charles B.
    Kalkeri, Raj
    Koidei, Fusataka
    Kushnir, Anna
    Tasker, Sybil
    Coleman, J. Robert
    VACCINE, 2020, 38 (14) : 2943 - 2948
  • [34] More Protection Against Respiratory Viral Infection: Respiratory Syncytial Virus Vaccines for Adults Aged 60 Years and Older
    Kotton, Camille Nelson
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (10) : 1419 - +
  • [35] Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses
    Jang, Yo Han
    Seong, Baik L.
    VACCINES, 2021, 9 (04)
  • [36] Reassortment incompetent live attenuated and replicon influenza vaccines provide improved protection against influenza in piglets
    Graaf-Rau, Annika
    Schmies, Kathrin
    Breithaupt, Angele
    Ciminski, Kevin
    Zimmer, Gert
    Summerfield, Artur
    Sehl-Ewert, Julia
    Lillie-Jaschniski, Kathrin
    Helmer, Carina
    Bielenberg, Wiebke
    Beilage, Elisabeth Grosse
    Schwemmle, Martin
    Beer, Martin
    Harder, Timm
    NPJ VACCINES, 2024, 9 (01)
  • [37] Protection conferred by virus-like particle vaccines against respiratory syncytial virus infection in mice by intranasal vaccination
    Gu, Hongjing
    Li, Tieling
    Han, Lina
    Zhu, Ping
    Zhang, Peirui
    Zhang, Shaogeng
    Sun, Sujing
    Duan, Yueqiang
    Xing, Li
    Zhao, Zhongpeng
    Lai, Chengcai
    Wen, Bohai
    Wang, Xiliang
    Yang, PengHui
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (04) : 1057 - 1064
  • [38] Recombinant Live Attenuated Influenza Virus Expressing Conserved G-Protein Domain in a Chimeric Hemagglutinin Molecule Induces G-Specific Antibodies and Confers Protection against Respiratory Syncytial Virus
    Jung, Yu-Jin
    Lee, Yu-Na
    Kim, Ki-Hye
    Lee, Youri
    Jeeva, Subbiah
    Park, Bo Ryoung
    Kang, Sang-Moo
    VACCINES, 2020, 8 (04) : 1 - 15
  • [39] Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children
    Belshe, RB
    Newman, FK
    Anderson, EL
    Wright, PF
    Karron, RA
    Tollefson, S
    Henderson, FW
    Meissner, HC
    Madhi, S
    Roberton, D
    Marshall, H
    Loh, R
    Sly, P
    Murphy, B
    Tatem, JM
    Randolph, V
    Hackell, J
    Gruber, W
    Tsai, TF
    JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (12): : 2096 - 2103
  • [40] Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines
    Crowe, JE
    VACCINE, 1998, 16 (14-15) : 1423 - 1432